VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SLPSimulations Plus, Inc.
$18.24$367M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSLPPrice Target
SLP logo

Simulations Plus, Inc. (SLP) Price Target Analysis

Updated Jun 18, 2026
Analyst Rating: Hold
Based on 9 analysts

1.4% Below Target

SLP trades 1.4% below Wall Street's consensus target of $18.50.

Current Price$18.24
Average Target$18.50
Low$18.50
Median$18.50
High$18.50

Analyst Target Range

Forward P/E21.1x
(Fair)
PEG Ratio—
Implied Growth+127.2%
(High Growth)
Analyst Spread0.0%
(High Agreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$18.24
Consensus$18.50
High$18.50
Low$18.50

Consensus Scenario Assumptions

The base valuation assumes SLP achieves its forward estimates and maintains a stable P/E multiple of 21.1x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 9 published analyst recommendations for SLP

56% hold / mixed conviction
+22
BearishBullish
Weighted analyst sentiment score based on 9 ratings
ConsensusHold
Coverage9 Analysts
Net Score+22
Bull / Bear44% / 0%
Strong Buy00%
Buy444%
Hold556%
Sell00%
Strong Sell00%
Strong Buy
00%
Buy
444%
Hold
556%
Sell
00%
Strong Sell
00%
Recommendation Mix44% Buy · 56% Hold · 0% Sell
Buy (4)Hold (5)Sell (0)

SLP Price Target Analysis

Updated June 22, 2026

As of June 22, 2026, Simulations Plus, Inc. (SLP) has a Wall Street consensus price target of $18.50, based on estimates from 9 covering analysts. With the stock currently trading at $18.24, this represents a potential upside of +1.4%. The company has a market capitalization of $367M.

Analyst price targets range from a low of $18.50 to a high of $18.50, representing a 0% spread in expectations. The median target of $18.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.

The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.

From a valuation perspective, SLP trades at a trailing P/E of -5.7x and forward P/E of 21.1x. Analysts expect EPS to grow +127.2% over the next year.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+40.8%
Industry Consensus
Avg Forward P/E
17.5x
(Fair)
Peers with Coverage
9 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
VEEV logo
VEEVVeeva Systems Inc.
$24.9B$153.30$235.38
+53.5%
Buy16.9x43
CERT logo
CERTCertara, Inc.
$862M$5.54$9.00
+62.5%
Buy14.4x16
SCYX logo
SCYXSCYNEXIS, Inc.
$25M$4.05—————
DSGN logo
DSGNDesign Therapeutics, Inc.
$777M$12.44$20.50
+64.8%
Buy—7
SDGR logo
SDGRSchrödinger, Inc.
$1.2B$15.76$18.00
+14.2%
Buy—12
RXRX logo
RXRXRecursion Pharmaceuticals, Inc.
$1.4B$3.23$5.50
+70.3%
Hold—10
ABSI logo
ABSIAbsci Corporation
$1.2B$7.41$10.03
+35.4%
Buy—12
TMO logo
TMOThermo Fisher Scientific Inc.
$172.7B$464.61$599.70
+29.1%
Buy18.7x42
A logo
AAgilent Technologies, Inc.
$35.9B$127.06$154.75
+21.8%
Buy21.0x41
CRL logo
CRLCharles River Laboratories International, Inc.
$8.9B$185.00$214.14
+15.8%
Buy16.7x37

SLP — Frequently Asked Questions

Quick answers to the most common questions about buying SLP stock.

What is the SLP stock price target for 2026?

The consensus price target for SLP is $18.5, close to the current price of $18.24 (1.4% implied move). Based on 9 analyst estimates, the stock appears fairly valued near current levels.

Is SLP a buy, sell, or hold?

SLP has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $18.5 implies 1.4% upside from current levels.

Is SLP stock overvalued or undervalued?

SLP trades at a forward P/E of 21.1111x, representing a moderate valuation. With analysts targeting $18.5 (1.4% implied move), the stock appears close to fair value.

How high can SLP stock go?

The most bullish Wall Street analyst has a price target of $18.5 for SLP, while the most conservative target is $18.5. The consensus of $18.5 represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover SLP stock?

SLP is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the SLP stock forecast?

The 12-month SLP stock forecast based on 9 Wall Street analysts shows a consensus price target of $18.5, with estimates ranging from $18.5 (bear case) to $18.5 (bull case). The median consensus rating is "Hold".

What is SLP's forward P/E ratio?

SLP trades at a forward P/E ratio of 21.1x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy SLP stock?

SLP appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $18.5 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do SLP price targets vary so much?

SLP analyst price targets range from $18.5 to $18.5, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $18.5 consensus represents the middle ground.

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare